New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

While tirzepatide has been on the market to treat type 2 diabetes under the name Mounjaro, Zepbound was just FDA approved for weight loss and most health insurances don’t cover it as a result ...

Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside ...

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ...

The monthly cost of a private prescription for Mounjaro is set to exceed £300 from next month – worrying news for the half a ...

A new study has found that tirzepatide, a weight-loss injection introduced in India this March, is more effective than semaglutide, a popular obesity drug already available in the country.